Dr. Scott D. Solomon

Akshay Desai is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Boston, Massachusetts. Dr. Desai is rated as an Elite provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Low Blood Pressure, Bone Marrow Aspiration, and Thrombectomy. Dr. Desai is currently accepting new patients.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is rated as an Elite provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

Dr. Marc Alan Pfeffer is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Victor J. Dzau professor of medicine at Harvard Medical School.Dr. Pfeffer received his medical degree from University of Oklahoma College of Medicine. He completed an internal medicine residency and a cardiology fellowship at Peter Bent Brigham Hospital (now BWH). Dr. Pfeffer is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.Dr. Pfeffer - along with Dr. Janice Pfeffer and Dr. Eugene Braunwald - is credited with introducing the concept that angiotensin-converting enzyme inhibitors (ACEIs) could mitigate adverse ventricular remodeling following myocardial infarction and that ACEI use would result in increased survival and other clinical benefits.His clinical interests include cardiovascular disease, congestive heart failure, coronary artery disease and valvular heart disease. The author of over 450 peer-reviewed publications, he has received research funding from the American Heart Association and National Institutes of Health. Dr. Pfeffer has been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr. Pfeffer is the recipient of the Clinical Research Prize and the James Herrick Award, both from the American Heart Association. Dr. Pfeffer is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, Acute Coronary Syndrome, and Pacemaker Implantation.